MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202631114748 A) filed by Raj Kumar Mandal; and Yogesh R on September 25, 2026, for A Novel Mucoadhesive Intranasal Pharmaceutical Composition For Enhanced Systemic And Lymphatic Delivery Of Antiretroviral Agents For The Management Of Human Immunodeficiency Virus Infection.
Inventors include Mr. Yogesh R; Mrs. Sobana Somasundaram; Ms. Srividhya R; Ms. Kp Varsha; Ms. Pooja Sri N. V; Mr. Ritthish G; Ms. Nisha S; Ms. Sai Gayathri R; Ms. K. Venkateshwari; and Mr. Raj Kumar Mandal.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: [34] The present invention discloses a mucoadhesive intranasal pharmaceutical composition designed for enhanced systemic and lymphatic delivery of antiretroviral therapeutic agents for the management of human immunodeficiency virus infection. The composition comprises one or more antiretroviral agents, pharmaceutically acceptable nasal vehicles and mucoadhesive polymers that prolong contact with the nasal mucosa and support controlled drug release. Optional nanosized carriers may improve drug loading, stability and absorption characteristics. The formulation is designed to reduce rapid mucociliary clearance and facilitate drug transport through systemic and lymphatic pathways following intranasal administration. for repeated therapy.
Disclaimer: Curated by HT Syndication.
